Comparison of analysis methodologies for net outcome with edoxaban vs warfarin in patients with atrial fibrillation in the ENGAGE AF-TIMI 48 trial

25 August 2018 (00:00 - 00:00)

Organised by:

Sign in to view the resources

Sign in for access options

About the speaker

Mrs Rose Hamershock

Brigham and Women's Hospital, Boston (United States of America)

6 More presentations in this session

Presentation thumbnail

Safety and effectiveness of dabigatran relative to warfarin in routine care: final results from a long-term monitoring program

Doctor K. Zint (Ingelheim, DE)

Presentation thumbnail

Use of machine learning to determine stroke severity of patients diagnosed with stroke in claims data

Doctor E. Kogan (Raritan, US)

Presentation thumbnail

National prescribing and adverse event rates of patients at risk of stroke with non-valvular AF from CPRD linked database: does 'big data' reflect clinical trials and identify areas for improvement?

Doctor V. Mehta (London, GB)

Abstract Slides

Presentation thumbnail

Comparison of long DAPT versus short DAPT in Japanese PCI patients based on healthcare information database

Doctor H. Yokoi (Fukuoka, JP)

Abstract Slides

Presentation thumbnail

Assessment of cardiovascular disease risk using different thresholds to define high risk on the pooled cohort equations

Doctor R. Rosenson (New York City, US)

Abstract Slides

Access the full session

Session thumbnail

Atrial fibrillation, stroke and cardiovascular risk

The Event

ESC Congress 2018

25 August - 29 August 2018

You may be interested in

Congress Presentation

Real-world evaluation of an algorithmic machine-learning-guided testing approach in stable chest pain: a multinational, multicohort study

Congress Session

Evolutions in arrythmia and syncope management

Congress Presentation

Wearable technologies and digital biomarkers: validity and usability

ESC 365 is supported by

novartis

Explore sponsored resources

ESC 365 is supported by

novartis

Explore sponsored resources